Chief Scientific Officer, Psylo
| Role | Organisation | Sources |
|---|---|---|
| Team Leader in Medicinal Chemistry (former) | Brain and Mind Centre | Startup Daily |
| Chief Scientific Officer | Psylo | Startup Daily (4 Jun 2024), Startup Daily (27 Oct 2022) |
| Team Leader in Medicinal Chemistry (former) | University of Sydney | Startup Daily |
Stories naming Dr Samuel Banister. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Psylo, a Sydney maker of psychedelic therapies, has landed a US$8 million seed round led by Tenmile while moving to the US; earlier raises in 2022 and 2021 are recalled.
Sydney psychedelic biotech Psylo has banked a $5 million seed round led by CSIRO's Main Sequence Ventures, its second raise since emerging from Startmate, to advance a fast-acting psilocybin therapy toward clinical trials.